Search research articles
Contact Us
Filters
Showing results (131-140 of 245) with videos related to
Page
of 25
Sort By:
Ophthalmology
|
November 1, 2006
Pars plana vitrectomy versus combined pars plana vitrectomy-scleral buckle for primary repair of pseudophakic retinal detachment
Eric D Weichel, Adam Martidis, Mitchell S Fineman, et al.
American Journal of Ophthalmology
|
September 20, 2015
Optical Coherence Tomography Angiography and En Face Optical Coherence Tomography Features of Paracentral Acute Middle Maculopathy
Jayanth Sridhar, Abtin Shahlaee, Ehsan Rahimy, et al.
American Journal of Ophthalmology
|
July 20, 2021
Fluctuations in Central Subfield Thickness Associated With Worse Visual Outcomes in Patients With Diabetic Macular Edema in Clinical Trial Setting
Matthew R Starr, Mirataollah Salabati, Raziyeh Mahmoudzadeh, et al.
Ophthalmology Science
|
November 7, 2022
Factors Associated with Fluctuations in Central Subfield Thickness in Patients with Diabetic Macular Edema Using Diabetic Retinopathy Clinical Research Protocols T and V
Ava Torjani, Raziyeh Mahmoudzadeh, Mirataollah Salabati, et al.
Ophthalmic Surgery, Lasers & Imaging Retina
|
May 26, 2021
Characterizing Progression to Neovascular AMD in Fellow Eyes of Patients Treated With Intravitreal Anti-VEGF Injections
Matthew R Starr, David Xu, Nicholas Boucher, et al.
Ophthalmology
|
July 13, 2014
Twenty-four-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration
Allen C Ho, Brandon G Busbee, Carl D Regillo, et al.
Ophthalmology
|
November 18, 2017
Long-Term Visual Outcomes and Safety Profile of 27-Gauge Pars Plana Vitrectomy for Posterior Segment Disease
M Ali Khan, Alexander Kuley, Christopher D Riemann, et al.
Seminars in Ophthalmology
|
September 5, 2015
Alternating Bi-Weekly Intravitreal Ranibizumab and Bevacizumab for Refractory Neovascular Age-Related Macular Degeneration with Pigment Epithelial Detachment<sup></sup>
Andre J Witkin, Nadim Rayess, Sunir J Garg, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye
|
October 12, 2011
Ranibizumab for eyes previously treated with pegaptanib or bevacizumab without clinical response
Richard S Kaiser, Omesh P Gupta, Carl D Regillo, et al.
Retina (Philadelphia, Pa.)
|
November 28, 2007
Intravitreal bevacizumab (avastin) in central retinal vein occlusion
Jason Hsu, Richard S Kaiser, Arunan Sivalingam, et al.
Page
of 25
Search research articles
Search
Showing results (131-140 of 245) with videos related to
Sort By:
Page
of 25
Ophthalmology
|
November 1, 2006
Pars plana vitrectomy versus combined pars plana vitrectomy-scleral buckle for primary repair of pseudophakic retinal detachment
Eric D Weichel, Adam Martidis, Mitchell S Fineman, et al.
American Journal of Ophthalmology
|
September 20, 2015
Optical Coherence Tomography Angiography and En Face Optical Coherence Tomography Features of Paracentral Acute Middle Maculopathy
Jayanth Sridhar, Abtin Shahlaee, Ehsan Rahimy, et al.
American Journal of Ophthalmology
|
July 20, 2021
Fluctuations in Central Subfield Thickness Associated With Worse Visual Outcomes in Patients With Diabetic Macular Edema in Clinical Trial Setting
Matthew R Starr, Mirataollah Salabati, Raziyeh Mahmoudzadeh, et al.
Ophthalmology Science
|
November 7, 2022
Factors Associated with Fluctuations in Central Subfield Thickness in Patients with Diabetic Macular Edema Using Diabetic Retinopathy Clinical Research Protocols T and V
Ava Torjani, Raziyeh Mahmoudzadeh, Mirataollah Salabati, et al.
Ophthalmic Surgery, Lasers & Imaging Retina
|
May 26, 2021
Characterizing Progression to Neovascular AMD in Fellow Eyes of Patients Treated With Intravitreal Anti-VEGF Injections
Matthew R Starr, David Xu, Nicholas Boucher, et al.
Ophthalmology
|
July 13, 2014
Twenty-four-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration
Allen C Ho, Brandon G Busbee, Carl D Regillo, et al.
Ophthalmology
|
November 18, 2017
Long-Term Visual Outcomes and Safety Profile of 27-Gauge Pars Plana Vitrectomy for Posterior Segment Disease
M Ali Khan, Alexander Kuley, Christopher D Riemann, et al.
Seminars in Ophthalmology
|
September 5, 2015
Alternating Bi-Weekly Intravitreal Ranibizumab and Bevacizumab for Refractory Neovascular Age-Related Macular Degeneration with Pigment Epithelial Detachment<sup></sup>
Andre J Witkin, Nadim Rayess, Sunir J Garg, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye
|
October 12, 2011
Ranibizumab for eyes previously treated with pegaptanib or bevacizumab without clinical response
Richard S Kaiser, Omesh P Gupta, Carl D Regillo, et al.
Retina (Philadelphia, Pa.)
|
November 28, 2007
Intravitreal bevacizumab (avastin) in central retinal vein occlusion
Jason Hsu, Richard S Kaiser, Arunan Sivalingam, et al.
Page
of 25